Obesity

• Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra - SAN FRANCISCO, Jan 12 (Reuters) - Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched erectile dysfunction drug ​Viagra in 1998, CEO Albert Bourla said on Monday. Bourla said
• 2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market - Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.
• Having a Cellphone at Younger Than 12 Could Carry Health Risks, Study Says - Researchers found higher rates of depression, poor sleep and obesity among tweens who had early access to a cellphone.